Larry Bird - PetIQ Independent Director
| PETQ Stock | USD 16.41 0.12 0.73% |
Director
Mr. Larry Bird serves as Independent Director of the company. Mr. Bird served as Senior Audit Partner at Deloitte Touche LLP until his retirement on June 3, 2017. As a Deloitte Audit Partner since 1989, Mr. Bird was actively engaged as the Lead Audit Partner responsible for planning and supervising audits for larger private companies and PCAOB Integrated Audits for publicly held companies spanning a variety of industries since 2018.
| Age | 63 |
| Tenure | 6 years |
| Address | 230 East Riverside Drive, Eagle, ID, United States, 83616 |
| Phone | 208 939 8900 |
| Web | https://petiq.com |
PetIQ Management Efficiency
The company has return on total asset (ROA) of 0.04 % which means that it generated a profit of $0.04 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0117 %, meaning that it created $0.0117 on every $100 dollars invested by stockholders. PetIQ's management efficiency ratios could be used to measure how well PetIQ manages its routine affairs as well as how well it operates its assets and liabilities. As of 04/29/2024, Return On Tangible Assets is likely to grow to 0. Also, Return On Capital Employed is likely to grow to 0.09. At this time, PetIQ's Total Current Liabilities is relatively stable compared to the past year. As of 04/29/2024, Change To Liabilities is likely to grow to about 61.9 M, while Liabilities And Stockholders Equity is likely to drop slightly above 571.2 M.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Charles Hinkaty | Prestige Brand Holdings | 64 | |
| Shikha Sharma | Dr Reddys Laboratories | 62 | |
| Michael McInnis | Regencell Bioscience Holdings | N/A | |
| Sean Keenan | Regencell Bioscience Holdings | 41 | |
| Andreas Wicki | Pacira Pharmaceuticals | 59 | |
| Prasad Menon | Dr Reddys Laboratories | 74 | |
| Michael Graves | Eagle Pharmaceuticals | 61 | |
| David Keyte | Regencell Bioscience Holdings | 59 | |
| Douglas Fulcher | Regencell Bioscience Holdings | N/A | |
| Mark Kronenfeld | Pacira Pharmaceuticals | 63 | |
| Sheila Hopkins | Prestige Brand Holdings | 64 | |
| Jerome Hauer | Emergent Biosolutions | 68 | |
| George Joulwan | Emergent Biosolutions | 80 | |
| Kenneth Booth | Regencell Bioscience Holdings | N/A | |
| Bharat Doshi | Dr Reddys Laboratories | 71 | |
| Kalpana Morparia | Dr Reddys Laboratories | 71 | |
| Lee Thomas | Regencell Bioscience Holdings | 71 | |
| Leo Puri | Dr Reddys Laboratories | 59 | |
| Kathryn Zoon | Emergent Biosolutions | 71 | |
| Antoinette Leatherberry | Zoetis Inc | 58 | |
| Ashok Ganguly | Dr Reddys Laboratories | 79 | |
Management Performance
| Return On Equity | 0.0117 | ||||
| Return On Asset | 0.04 |
PetIQ Inc Leadership Team
Elected by the shareholders, the PetIQ's board of directors comprises two types of representatives: PetIQ inside directors who are chosen from within the company, and outside directors, selected externally and held independent of PetIQ. The board's role is to monitor PetIQ's management team and ensure that shareholders' interests are well served. PetIQ's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, PetIQ's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gary Michael, Independent Director | ||
| John Pearson, Executive Products | ||
| Ronald Kennedy, Independent Director | ||
| William Carter, Executive Counsel | ||
| Will Santana, Director | ||
| Mark First, Lead Independent Director | ||
| Larry Bird, Independent Director | ||
| John Newland, CFO, Secretary | ||
| Katie Turner, IR Contact Officer | ||
| Robert Herrman, Gen VP | ||
| Michael Smith, Executive Vice President Products | ||
| James Clarke, Independent Director | ||
| McCord Christensen, Chairman of the Board, CEO | ||
| Zvi Glasman, Chief Officer | ||
| Scott Huff, Director | ||
| Susan Sholtis, Independent Director |
PetIQ Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is PetIQ a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0117 | ||||
| Return On Asset | 0.04 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 836.39 M | ||||
| Shares Outstanding | 29.48 M | ||||
| Shares Owned By Insiders | 6.93 % | ||||
| Shares Owned By Institutions | 98.39 % | ||||
| Number Of Shares Shorted | 1.83 M | ||||
| Price To Earning | 130.31 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards PetIQ in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, PetIQ's short interest history, or implied volatility extrapolated from PetIQ options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as PetIQ Inc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetIQ Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for PetIQ Stock analysis
When running PetIQ's price analysis, check to measure PetIQ's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetIQ is operating at the current time. Most of PetIQ's value examination focuses on studying past and present price action to predict the probability of PetIQ's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetIQ's price. Additionally, you may evaluate how the addition of PetIQ to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Stocks Directory Find actively traded stocks across global markets | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
Is PetIQ's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PetIQ. If investors know PetIQ will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PetIQ listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.023 | Earnings Share 0.07 | Revenue Per Share 37.823 | Quarterly Revenue Growth 0.195 | Return On Assets 0.04 |
The market value of PetIQ Inc is measured differently than its book value, which is the value of PetIQ that is recorded on the company's balance sheet. Investors also form their own opinion of PetIQ's value that differs from its market value or its book value, called intrinsic value, which is PetIQ's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PetIQ's market value can be influenced by many factors that don't directly affect PetIQ's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PetIQ's value and its price as these two are different measures arrived at by different means. Investors typically determine if PetIQ is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PetIQ's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.